Skip to content
Coromandel International logo

Coromandel International

COROMANDEL NSE
₹1,837.00 No trade today
P/E
29.58
View as Markdown
MCP
Close 4 Nov 2026 ₹1,837.00 −313.10 −14.6% 1Y
Start ₹2,150.10

Key Fundamentals

MidcapFertilizers & AgrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
22.00%
Debt to Equity
0.12
EPS (TTM)
₹62.11
Book Value
₹425.67
Market Cap
—
P/E (TTM)
29.58
P/B
4.32
ROE
16.40%
Dividend Yield
0.61%
EBITDA
₹3,564 Cr
52W High
₹2,499.00
52W Low
₹1,651.10
Volume
0

Peer Comparison

Commodities › Chemicals › Fertilizers

Coromandel International peer comparison
Coromandel International (this company)
₹1,837.0029.58₹53,760 Cr4.320.61%16.40%22.00%₹32,602 Cr₹1,778 Cr
Fertilisers & Chemical Travancore
₹764.05—₹48,951 Cr36.610.03%−2.94%4.02%₹5,934 Cr−₹106 Cr
Chambal Fertilisers & Chemicals
₹394.158.19₹15,752 Cr1.521.31%20.00%25.20%₹20,123 Cr₹1,928 Cr
Paradeep Phosphates
₹137.2112.23₹14,054 Cr1.991.12%16.20%15.40%₹23,447 Cr₹1,073 Cr
Madhya Bharat Agro
₹187.2953.06₹8,452 Cr10.110.27%31.30%19.30%₹1,874 Cr₹155 Cr
Krishana Phoschem
₹240.2937.78₹7,305 Cr13.250.22%38.20%27.20%₹2,555 Cr₹196 Cr
Gujarat State Fertilizers & Chemicals
₹140.748.09₹5,467 Cr0.433.67%5.51%7.16%₹12,344 Cr₹693 Cr
Median 7 companies₹240.2920.91₹14,054 Cr4.320.61%16.40%19.30%₹12,344 Cr₹693 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

52 Average

Data confidence 100/100

Category scores

Quality
49
Average
Returns, margins, earnings quality 22% weight
Valuation
54
Average
Cheap vs sector & own history 24% weight
Growth
88
Strong
Sales & profit trajectory 9% weight
Financial Health
51
Average
Solvency, leverage, coverage 9% weight
Momentum
30
Poor
Trend strength, vol-adjusted 12% weight
Ownership
56
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallNeutral757
OscillatorsNeutral252
Moving AveragesNeutral505

Key readings

RSI (14)
56.86
Neutral
MACD (12,26,9)
−20.47
Bullish
SMA (50)
1,844.48
Bearish
SMA (200)
2,000.35
Bearish

As of

Analyst Rating

Based on 9 analysts
BUY89%

8 of 9 analysts rate Buy, 1 Hold, 0 Sell.

As of

BUY
8
89%
HOLD
1
11%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+10.61%
5Y+17.29%
3Y+2.04%
1Y+30.70%
TTM+23.50%

Net profit

Net profit growth by window
10Y+18.19%
5Y+7.39%
3Y−1.94%
1Y−7.64%
TTM−20.87%

Operating cash flow

Operating cash flow growth by window
10Y+56.22%
5Y−17.79%
3Y+38.14%
1Y−36.77%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+3.57 pp
5Y−3.75 pp
3Y+0.48 pp
1Y−0.43 pp
TTM−1.07 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹10,031 Cr
Mar 2018₹11,083 Cr
Mar 2019₹13,225 Cr
Mar 2020₹13,137 Cr
Mar 2021₹14,182 Cr
Mar 2022₹19,111 Cr
Mar 2023₹29,628 Cr
Mar 2024₹22,058 Cr
Mar 2025₹24,085 Cr
Mar 2026₹31,480 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹477 Cr
Mar 2018₹691 Cr
Mar 2019₹720 Cr
Mar 2020₹1,065 Cr
Mar 2021₹1,329 Cr
Mar 2022₹1,528 Cr
Mar 2023₹2,013 Cr
Mar 2024₹1,641 Cr
Mar 2025₹2,055 Cr
Mar 2026₹1,898 Cr

Analyst Forecasts

Forecast For
Sep 26 consensus · EBITDA
₹791 Cr −1.8% vs Jun 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 3 Nov 2026
AI opinion · based on fundamentals
Risk medium

Coromandel International trades at ₹1,812 as of 2026-11-03 with a market cap of ₹51,954 Cr and a P/E of 29.17x. The company shows strong long-term sales growth (10-year CAGR of 11%) and a near-debt-free balance sheet (debt-to-equity of 0.12), but recent profitability has contracted with TTM profit declining 6% and the stock down 21% over the past year from a 52-week high of ₹2,499.

Bull Case 7
  • Robust long-term compounded sales growth of 11% over 10 years and an accelerating TTM sales growth of 24%, indicating strong top-line momentum
  • Near debt-free balance sheet with a debt-to-equity ratio of just 0.12, providing significant financial flexibility and low interest-rate risk
  • Healthy return on capital employed (ROCE) of 21.08%, well above the cost of capital for most Indian manufacturers, reflecting efficient capital allocation
  • Strong 10-year ROE track record averaging 22%, demonstrating consistent value creation for shareholders over a full business cycle
  • Compounded stock price CAGR of 20% over 10 years and 16% over 5 years, reflecting sustained long-term wealth creation
  • 5-year compounded sales growth of 17% significantly outpaces the 10-year rate of 11%, suggesting the business has structurally scaled up in recent years
  • Price-to-book ratio of 4.26x combined with an ROE of 14.45% implies the company continues to generate returns above book value cost expectations for the chemicals sector
Bear Case 7
  • TTM profit has declined by 6%, and 3-year compounded profit growth is negative at -1%, indicating a meaningful earnings downcycle despite revenue growth
  • Stock has fallen 21% over the past one year, significantly underperforming broader indices, reflecting deteriorating market sentiment
  • Wide margin divergence: TTM sales grew 24% but TTM profit fell 6%, pointing to severe margin compression likely driven by input cost pressures or pricing headwinds
  • P/E of 29.17x appears elevated relative to the negative TTM profit growth of -6%, suggesting the valuation prices in a recovery that has yet to materialize in earnings
  • Last-year ROE of 16% has fallen from the 10-year average of 22% and 5-year average of 20%, indicating a declining return profile
  • Dividend yield of only 0.63% provides minimal income cushion for investors during a period of falling stock price and earnings contraction
  • 5-year compounded profit growth of only 8% lags the 5-year sales CAGR of 17% by a wide margin, suggesting structural margin dilution rather than a one-off event

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

12d ago

TL;DR: Limited news flow for Coromandel International this period. A single large block trade worth ₹58.66 crore on Sep 24 suggests institutional activity but carries no directional signal on its own. No material headwinds or positive catalysts were reported. Investors should watch for upcoming quarterly results and fertilizer subsidy policy updates for clearer directional cues.

Quarterly Results

₹ Cr
COROMANDEL quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
5,693
6,988
5,464
3,913
4,729
7,433
6,935
4,988
7,042
9,654
8,779
6,004
8,165
Expenses
4,988
5,933
5,115
3,650
4,238
6,471
6,222
4,579
6,260
8,508
7,980
5,516
7,409
Operating Profit
706
1,055
349
263
490
962
713
409
782
1,147
800
488
756
OPM %
12%
15%
6%
7%
10%
13%
10%
8%
11%
12%
9%
8%
9%
Other Income
44
45
59
84
54
65
114
473
84
116
83
−6
50
Interest
41
46
38
62
57
66
73
66
68
102
84
89
89
Depreciation
48
54
64
63
65
69
71
85
121
102
147
165
203
PBT
661
1,000
306
222
422
892
683
731
677
1,059
653
228
514
Tax %
25%
25%
25%
26%
27%
26%
26%
21%
26%
25%
25%
50%
26%
Net Profit
494
755
228
164
309
659
508
578
502
793
488
115
382
EPS (₹)
16.8
25.71
7.85
5.45
10.56
22.55
17.37
19.67
17.13
27.31
17.15
4.74
12.91

Profit & Loss

₹ Cr
COROMANDEL profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
11,306
11,481
10,031
11,083
13,225
13,137
14,182
19,111
29,628
22,058
24,085
31,480
32,602
Expenses
10,450
10,712
9,048
9,822
11,775
11,400
12,193
16,954
26,726
19,678
21,508
28,248
29,412
Operating Profit
856
769
983
1,261
1,450
1,737
1,989
2,156
2,902
2,380
2,577
3,232
3,190
OPM %
8%
7%
10%
11%
11%
13%
14%
11%
10%
11%
11%
10%
10%
Other Income
50
87
54
55
8
35
76
141
171
223
703
262
243
Interest
210
221
224
178
251
235
106
75
190
187
262
343
364
Depreciation
105
106
101
99
114
158
173
173
182
229
290
534
616
PBT
592
529
712
1,038
1,093
1,379
1,786
2,050
2,701
2,188
2,728
2,617
2,454
Tax %
32%
32%
33%
33%
34%
23%
26%
25%
25%
25%
25%
27%
—
Net Profit
402
357
477
691
720
1,065
1,329
1,528
2,013
1,641
2,055
1,898
1,778
EPS (₹)
13.8
12.27
16.35
23.64
24.63
36.36
45.3
52.08
68.46
55.78
70.14
66.31
62.11
Div. Payout %
33%
33%
31%
27%
26%
33%
26%
23%
18%
11%
21%
3%
—

Balance Sheet

₹ Cr
COROMANDEL balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
29
29
29
29
29
29
29
29
29
29
29
30
Reserves
2,173
2,605
2,862
2,867
3,329
4,288
5,121
6,329
7,878
9,390
11,058
12,528
Borrowings
2,288
2,677
2,228
2,728
2,954
2,019
385
395
393
492
780
1,506
Other Liabilities
3,872
3,871
3,526
4,224
4,261
3,812
3,360
4,532
5,934
5,933
7,049
10,397
Total Liabilities
8,362
9,182
8,645
9,848
10,574
10,149
8,895
11,285
14,235
15,845
18,917
24,461
Fixed Assets
1,380
1,320
1,328
1,327
1,309
2,032
2,015
2,092
2,200
3,112
4,139
6,737
CWIP
46
42
22
48
191
65
90
141
399
235
396
348
Investments
352
477
388
221
201
211
214
243
287
854
1,031
2,044
Other Assets
6,583
7,343
6,907
8,252
8,873
7,840
6,576
8,809
11,348
11,644
13,351
15,331
Total Assets
8,362
9,182
8,645
9,848
10,574
10,149
8,895
11,285
14,235
15,845
18,917
24,461

Cash Flow

₹ Cr
COROMANDEL cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
86
18
915
263
526
1,862
4,150
2,078
591
1,428
2,464
1,558
Investing
−216
−61
−79
38
−597
−220
−1,245
−1,622
640
−1,333
−2,638
−559
Financing
−64
8
−864
−1
−244
−1,723
−2,263
−443
−543
−363
−698
−831
Net Cash Flow
−194
−34
−28
300
−314
−82
642
14
688
−269
−872
168
Free Cash Flow
−6
−89
834
134
255
1,606
3,958
1,801
22
910
2,030
22
CFO/EBITDA
27
25
120
49
62
128
232
119
45
86
123
71

Ratios

COROMANDEL financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
47
52
59
52
50
48
14
5
7
23
19
24
Inventory Days
96
98
88
109
127
109
98
94
69
102
98
111
Days Payable
131
135
150
162
147
135
110
100
83
119
123
136
Cash Conversion Cycle
12
15
−3
−2
30
22
2
−1
−7
6
−7
−1
Working Capital Days
11
24
40
27
42
65
64
41
37
46
28
35
ROCE %
19%
15%
18%
23%
23%
26%
32%
35%
38%
26%
23%
22%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Coromandel International insights

65 extracted metrics across FY12–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 56.34%
  • DIIs 20.48%
  • FIIs 11.33%
  • Public 7.31%
  • Others 4.53%

0.01% of promoter holding pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Coromandel International

What does Coromandel International Ltd do?
Business Segments a) Nutrient and Other Allied Business (88% in FY26 vs 90% in FY25):: i) Fertilizers: It manufactures NPK, DAP, SSP, MOP, and urea. It is India's 2nd-largest manufacturer and marketer of phosphatic fertilizers, the largest manufacturer and marketer of SSP, the largest…
Where is Coromandel International Ltd (COROMANDEL) listed?
Coromandel International Ltd trades as COROMANDEL on the NSE and under code 506395 on the BSE.
Which sector does Coromandel International Ltd belong to?
Coromandel International Ltd is classified under the Chemicals sector, in the Fertilizers industry.
What is the PE ratio of Coromandel International Ltd?
Coromandel International Ltd trades at a PE ratio of 29.58 as of 4 Nov 2026, on earnings per share of ₹62.11, against a book value of ₹425.67 per share.
What is the 52-week high and low of Coromandel International Ltd?
Over the last 52 weeks Coromandel International Ltd has traded between ₹1,651.1 and ₹2,499 as of 4 Nov 2026.
Does Coromandel International Ltd pay dividends?
Coromandel International Ltd has a dividend yield of 0.61%.
What is the Return on Equity (ROE) of Coromandel International Ltd?
Coromandel International Ltd reported a return on equity of 16.40%. Its debt-to-equity ratio is 0.12.

Company Information

Business Segments a) Nutrient and Other Allied Business (88% in FY26 vs 90% in FY25):: i) Fertilizers: It manufactures NPK, DAP, SSP, MOP, and urea. It is India's 2nd-largest manufacturer and marketer of phosphatic fertilizers, the largest manufacturer and marketer of SSP, the largest private-sector NPK player, and a pioneering leader in the Nano DAP segment. It also holds a 35% share in the unique products segment and a 17.5% market share on a consumption basis. ii) Specialty Nutrients: The company is the pioneer & market leader in India's specialty nutrients segment, offering water-soluble fertilizers, secondary and micronutrients, and nano fertilizer products. iii) Organic Fertilizers: The company markets organic fertilizers, producing a range of products derived from natural sources such as city waste, sugarcane molasses and its by-products, oil cakes, and gypsum. b) Crop Protection (12% in FY26 vs 10% in FY25):: i) Crop Protection: The company manufactures and markets a range of insecticides, fungicides, herbicides, plant growth regulators, technicals and formulations in India and international markets. It is the country's 4th-largest agrochemical player by value, with the capability to manufacture 20 technicals and intermediates. It is also the 2nd-largest manufacturer of Malathion globally and a major manufacturer of Phenthoate in Asia. ii) Bio Products: Bio Products business focuses on plant-based extracts for agricultural applications, offering a comprehensive portfolio of biopesticides based on Azadirachtin, plant-derived biostimulants, anti-transpirants and non-ionic spreaders. It holds a global leadership position in the Azadirachtin market, with a presence across more than 40 countries in the Americas, Europe and Asia. Sale Volumes (in Lakh MT): NPK+DAP: 42.77 in FY26 vs 39.88 in FY25 SSP: 8.41 in FY26 vs 7.73 in FY25 MOP: 0.67 in FY26 vs 0.69 in FY25 Urea: 22.65 in FY26 vs 13.59 in FY25 Geographical Split Domestic: 94% in FY26 vs 95% in FY25 Exports: 6% in FY26 vs 5% in FY25 Retail Presence The company operates India's largest agri-retail network with over 1,200 agri-retail outlets across Andhra Pradesh, Telangana, Karnataka, Tamil Nadu and Maharashtra. It is supported by over 3,000 marketing professionals and serves more than 5 Mn farmers across its operating markets. It has a network of 12,000 channel partners. New Product Launches In FY26, Coromandel expanded its portfolio with new launches across Specialty Nutrients, Crop Protection and Bio Products. It's key additions included Fertinex 28:28:0, GypMax, Novonese, Organovita and Summit in Specialty Nutrients; Daliso, Ghibli, Chhaava and Invicto in Crop Protection; and CoroBT, GroBT, Coroscens, CoroShakti and other biological solutions to strengthen its bio-products portfolio. Manufacturing Capabilities The company operates 21 manufacturing facilities across India, with a total capacity of: Fertilizers: 3.5 Mn MT SSP: 1 Mn MT Specialty Nutrients: 87,500 MT Nano Fertilizers: 10,000 KL Crop Protection Chemicals: 0.87 Lakh MT Bio Products: 22.5 MT Expansion & Backward Integration The company commissioned a 2,000 TPD sulphuric acid plant and a 650 TPD phosphoric acid plant at Kakinada in Q4 FY26, for Rs. 1,100 Cr. It also advanced construction of the 7.5 lakh TPA NPK granulation Train H at Kakinada, expected to increase the site's total fertilizer capacity to 30 lakh TPAby Q4 FY27. Additionally, its Senegal rock phosphate project, where the company holds a 53.8% stake, commissioned a fixed processing plant and ramped up production to secure raw material supplies for the Kakinada phosphoric acid facility. It also added a 9 KTPA technical plant at Dahej for off-patent fungicides, along with capacity additions for key technical molecules at Ankleshwar and a herbicide block expansion at Sarigam. Acquisitions In Aug 2025, the company acquired a 53.13% controlling stake in NACL Industries for Rs. 820 Cr. MoU In Nov 2025, the company signed a non-binding MoU with the Andhra Pradesh Economic Development Board to explore investments of up to Rs. 2,000 Cr in Andhra Pradesh. Focus The company expects a 20-25% revenue growth in the crop protection business.

Website coromandel.biz
CEO Mr. Arun Alagappan
Employees 5,540
Listed 31 May 1995
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/COROMANDEL.md for Coromandel International Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Fertilizer & Agrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month